Option Care Health Q3 revenue up 17%; updated 2024 guidance cites supply disruption
Option Care Health reported third-quarter 2024 net revenue of $1,278.5 million, up 17.0%, but net income of $53.9 million was down 4.3% and diluted EPS was flat at $0.31. The company said a supply disruption tied to Hurricane Helene will negatively affect fourth-quarter results, and it updated its full-year 2024 guidance to reflect this.
Key points
- Net revenue of $1,278.5 million, up 17.0% from $1,093.0 million in Q3 2023
- Net income of $53.9 million, or $0.31 diluted EPS, versus $56.3 million, or $0.31, a year earlier; adjusted diluted EPS was $0.41 versus $0.40
- Updated 2024 guidance: net revenue of $4.9 billion to $4.95 billion and adjusted EBITDA of $438 million to $443 million, with the Q4 hit from supply disruption for intravenous solution bags
- Cash flow from operations was $160.4 million versus $61.0 million in Q3 2023; the company repurchased about $41.9 million of stock in the quarter
The filing
Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.